Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 1999; Volume 55,Issue 2

Accelerated Communication

  • You have access
    Modulation of Relative Intrinsic Activity of Agonists at theAlpha-2A Adrenoceptor by Mutation of Residue 351 of G Protein Gi1α
    Vicky N. Jackson, Daljit S. Bahia and Graeme Milligan
    Molecular Pharmacology February 1999, 55 (2) 195-201; DOI: https://doi.org/10.1124/mol.55.2.195

Articles

  • You have access
    Increased Site-Specific Phosphorylation of Tyrosine Hydroxylase Accompanies Stimulation of Enzymatic Activity Induced by Cessation of Dopamine Neuronal Activity
    Jow Y. Lew, Antonio Garcia-Espana, Kwan Y. Lee, Kenneth D. Carr, Menek Goldstein, John W. Haycock and Emanuel Meller
    Molecular Pharmacology February 1999, 55 (2) 202-209; DOI: https://doi.org/10.1124/mol.55.2.202
  • You have access
    Pivotal Role of an Aspartate Residue in Sodium Sensitivity and Coupling to G Proteins of Neurotensin Receptors
    Stéphane Martin, Jean-Marie Botto, Jean-Pierre Vincent and Jean Mazella
    Molecular Pharmacology February 1999, 55 (2) 210-215; DOI: https://doi.org/10.1124/mol.55.2.210
  • You have access
    DNA Damage Signals Induction of Fas Ligand in Tumor Cells
    Yin-Yuan Mo and William T. Beck
    Molecular Pharmacology February 1999, 55 (2) 216-222; DOI: https://doi.org/10.1124/mol.55.2.216
  • You have access
    Autoantibodies against Cytochromes P-4502E1 and P-4503A in Alcoholics
    Simon D. Lytton, Anders Helander, Zhi-Qi Zhang-Gouillon, Knut Stokkeland, Roberta Bordone, Sarino Aricò, Emanuele Albano, Samuel W. French and Magnus Ingelman-Sundberg
    Molecular Pharmacology February 1999, 55 (2) 223-233; DOI: https://doi.org/10.1124/mol.55.2.223
  • You have access
    Characterization of a Bioengineered Chimeric Na+-Nucleoside Transporter
    Juan Wang and Kathleen M. Giacomini
    Molecular Pharmacology February 1999, 55 (2) 234-240; DOI: https://doi.org/10.1124/mol.55.2.234
  • You have access
    Use of Chimeric Enzymes and Site-Directed Mutagenesis for Identification of Three Key Residues Responsible for Differences in Steroid Hydroxylation between Canine Cytochromes P-450 3A12 and 3A26
    David J. Fraser, You Qun He, Greg R. Harlow and James R. Halpert
    Molecular Pharmacology February 1999, 55 (2) 241-247; DOI: https://doi.org/10.1124/mol.55.2.241
  • You have access
    The α9 Nicotinic Acetylcholine Receptor Shares Pharmacological Properties with Type A γ-Aminobutyric Acid, Glycine, and Type 3 Serotonin Receptors
    Carla V. Rothlin, Eleonora Katz, Miguel Verbitsky and A. Belén Elgoyhen
    Molecular Pharmacology February 1999, 55 (2) 248-254; DOI: https://doi.org/10.1124/mol.55.2.248
  • You have access
    Stimulation of the Extracellular Signal-Regulated Kinase 1/2 Pathway by Human Beta-3 Adrenergic Receptor: New Pharmacological Profile and Mechanism of Activation
    C. C. Gerhardt, J. Gros, A. D. Strosberg and T. Issad
    Molecular Pharmacology February 1999, 55 (2) 255-262; DOI: https://doi.org/10.1124/mol.55.2.255
  • You have access
    Replacement of Threonine 394 by Alanine Facilitates Internalization and Resensitization of the Rat μ Opioid Receptor
    Ronald Wolf, Thomas Koch, Stefan Schulz, Marcus Klutzny, Helmut Schröder, Evelyn Raulf, Frank Bühling and Volker Höllt
    Molecular Pharmacology February 1999, 55 (2) 263-268; DOI: https://doi.org/10.1124/mol.55.2.263
  • You have access
    The Steroid Promegestone Is a Noncompetitive Antagonist of theTorpedo Nicotinic Acetylcholine Receptor that Interacts with the Lipid-Protein Interface
    Michael P. Blanton, Yu Xie, Lawrence J. Dangott and Jonathan. B. Cohen
    Molecular Pharmacology February 1999, 55 (2) 269-278; DOI: https://doi.org/10.1124/mol.55.2.269
  • You have access
    A Novel Positive Regulatory Element That Enhances HamsterCYP2A8 Gene Expression Mediated by Xenobiotic Responsive Element
    Kouichi Kurose, Masahiro Tohkin and Morio Fukuhara
    Molecular Pharmacology February 1999, 55 (2) 279-287; DOI: https://doi.org/10.1124/mol.55.2.279
  • You have access
    Inhibition of Cardiac L-Type Calcium Channels by Epoxyeicosatrienoic Acids
    Jianyong Chen, Jorge H. Capdevila, Darryl C. Zeldin and Robert L. Rosenberg
    Molecular Pharmacology February 1999, 55 (2) 288-295; DOI: https://doi.org/10.1124/mol.55.2.288
  • You have access
    No Role for Ca++ or Protein Kinase C inAlpha-1A Adrenergic Receptor Activation of Mitogen-Activated Protein Kinase Pathways in Transfected PC12 Cells
    Alf Berts, Hongying Zhong and Kenneth P. Minneman
    Molecular Pharmacology February 1999, 55 (2) 296-303; DOI: https://doi.org/10.1124/mol.55.2.296
  • You have access
    Inhibition of Astroglial Nitric Oxide Synthase Type 2 Expression by Idazoxan
    D. L. Feinstein, D. J. Reis and S. Regunathan
    Molecular Pharmacology February 1999, 55 (2) 304-308; DOI: https://doi.org/10.1124/mol.55.2.304
  • You have access
    Dexamethasone Stimulates Human A1 Adenosine Receptor (A1AR) Gene Expression through Multiple Regulatory Sites in Promoter B
    Hongzu Ren and Gary L. Stiles
    Molecular Pharmacology February 1999, 55 (2) 309-316; DOI: https://doi.org/10.1124/mol.55.2.309
  • You have access
    Inhibition of Glucocorticoid Receptor Binding by Nitric Oxide
    Mario D. Galigniana, Graciela Piwien-Pilipuk and Jamil Assreuy
    Molecular Pharmacology February 1999, 55 (2) 317-323; DOI: https://doi.org/10.1124/mol.55.2.317
  • You have access
    Distinct Mechanisms for Activation of the Opioid Receptor-Like 1 and κ-Opioid Receptors by Nociceptin and Dynorphin A
    Catherine Mollereau, Lionel Mouledous, Sophie Lapalu, Gilles Cambois, Christiane Moisand, Jean-Luc Butour and Jean-Claude Meunier
    Molecular Pharmacology February 1999, 55 (2) 324-331; DOI: https://doi.org/10.1124/mol.55.2.324
  • You have access
    Three Distinct d-Amino Acid Substitutions Confer Potent Antiangiogenic Activity on an Inactive Peptide Derived from a Thrombospondin-1 Type 1 Repeat
    David W. Dawson, Olga V. Volpert, S. Frieda A. Pearce, Andrew J. Schneider, Roy L. Silverstein, Jack Henkin and Noël P. Bouck
    Molecular Pharmacology February 1999, 55 (2) 332-338; DOI: https://doi.org/10.1124/mol.55.2.332
  • You have access
    Constitutively Active Alpha-1b Adrenergic Receptor Mutants Display Different Phosphorylation and Internalization Features
    Sakina Mhaouty-Kodja, Larry S. Barak, Alexander Scheer, Liliane Abuin, Dario Diviani, Marc G. Caron and Susanna Cotecchia
    Molecular Pharmacology February 1999, 55 (2) 339-347; DOI: https://doi.org/10.1124/mol.55.2.339
  • You have access
    A Structure-Based Approach to Nicotinic Receptor Pharmacology
    Stephen E. Ryan and John E. Baenziger
    Molecular Pharmacology February 1999, 55 (2) 348-355; DOI: https://doi.org/10.1124/mol.55.2.348
  • You have access
    Isolation of cDNAs Encoding Cellular Drug-Binding Proteins Using a Novel Expression Cloning Procedure: Drug-Western
    Hideki Tanaka, Nobuko Ohshima and Hiroyoshi Hidaka
    Molecular Pharmacology February 1999, 55 (2) 356-363; DOI: https://doi.org/10.1124/mol.55.2.356
  • You have access
    Purine and Pyrimidine Nucleotides Inhibit a Noninactivating K+ Current and Depolarize Adrenal Cortical Cells through a G Protein-Coupled Receptor
    Lin Xu and John J. Enyeart
    Molecular Pharmacology February 1999, 55 (2) 364-376; DOI: https://doi.org/10.1124/mol.55.2.364
  • You have access
    Enhanced Binding to DNA and Topoisomerase I Inhibition by an Analog of the Antitumor Antibiotic Rebeccamycin Containing an Amino Sugar Residue
    Christian Bailly, Xiaogang Qu, Fabrice Anizon, Michelle Prudhomme, Jean-François Riou and Jonathan B. Chaires
    Molecular Pharmacology February 1999, 55 (2) 377-385; DOI: https://doi.org/10.1124/mol.55.2.377
  • You have access
    The Startle Disease Mutation Q266H, in the Second Transmembrane Domain of the Human Glycine Receptor, Impairs Channel Gating
    Andrew J. Moorhouse, Patrice Jacques, Peter H. Barry and Peter R. Schofield
    Molecular Pharmacology February 1999, 55 (2) 386-395; DOI: https://doi.org/10.1124/mol.55.2.386
  • You have access
    Induction of p53-Dependent, Insulin-Like Growth Factor-Binding Protein-3-Mediated Apoptosis in Glioblastoma Multiforme Cells by a Protein Kinase Cα Antisense Oligonucleotide
    Li Shen, Nicholas M. Dean and Robert I. Glazer
    Molecular Pharmacology February 1999, 55 (2) 396-402; DOI: https://doi.org/10.1124/mol.55.2.396
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 55 (2)
Molecular Pharmacology
Vol. 55, Issue 2
1 Feb 1999
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Accelerated Communication
  • Articles
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Cardiac Safety of Doxorubicin
  • Wnt Signaling and Drug Resistance in Cancer
  • Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-α in Primary Rat Adipocytes
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics